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RARE-Bestpractices (http://www.rarebestpractices.eu)
is a 4-year project (2013-2016) funded by the EC FP7.
The project aims at improving clinical management of
patients with rare diseases (RD) and at narrowing the
existing gap in quality of healthcare among countries.
Methods
RARE-Bestpractices (http://www.rarebestpractices.eu)
involves 9 EU countries, including 15 partners from aca-
demic institutions, governmental bodies, patient organiza-
tions and networks, which will exploit the added value of
integrating different contributions and viewpoints.
The platform is developed involving both experts in RD
research as well as experts in clinical practice guidelines
(CPG) and systematic reviews.
Results
Project expected outputs include: 1) identification of chal-
lenges to be considered in deriving high quality standards
for CPG on RD; 2) transparent procedures and criteria for
the evaluation of CPG and their collection in a publicly
searchable database; 3) identification of notation criteria to
improve user understandability and implementation of
CPG; 4) production of mechanisms to assess RD clinical
research needs; 5) development of training activities
targeted to key stakeholders to disseminate process and
tools for developing and evaluating CPG; 6) the publica-
tion of a new scientific journal (http://rarejournal.org)
Discussion
RARE-Bestpractices addresses the demands from both
patients and health care providers for updated and high
quality CPG on RD. The project will meet the require-
ments laid down by to the Directive 2011/24/EU, which
endorses EU MS to develop European Reference Networks
(ERNs) for RD; in fact, one main criterion for ERNs should
be the competence to produce CPG and actively dissemi-
nate them among Centers of Expertise.
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